What is the price-to-earnings ratio of Eckert & Ziegler Strahlen und Medizintechnik?
The price-earnings ratio of Eckert & Ziegler Strahlen und Medizintechnik is currently 3.58.
Eckert & Ziegler Strahlen und Medizintechnik's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Comparing Eckert & Ziegler Strahlen und Medizintechnik's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
The P/S ratio is instrumental for investors evaluating Eckert & Ziegler Strahlen und Medizintechnik's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Variations in Eckert & Ziegler Strahlen und Medizintechnik’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
The price-earnings ratio of Eckert & Ziegler Strahlen und Medizintechnik is currently 3.58.
The price-to-earnings ratio of Eckert & Ziegler Strahlen und Medizintechnik has increased by 5.6% increased compared to last year.
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Yes, the price-to-earnings ratio of Eckert & Ziegler Strahlen und Medizintechnik is high compared to other companies.
An increase in the price-earnings ratio of Eckert & Ziegler Strahlen und Medizintechnik would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
A decrease in the price-earnings ratio of Eckert & Ziegler Strahlen und Medizintechnik would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
Some factors that influence the price-earnings ratio of Eckert & Ziegler Strahlen und Medizintechnik are the company's growth, financial position, industry development, and the overall economic situation.
Over the past 12 months, Eckert & Ziegler Strahlen und Medizintechnik paid a dividend of 0.5 EUR . This corresponds to a dividend yield of about 1.08 %. For the coming 12 months, Eckert & Ziegler Strahlen und Medizintechnik is expected to pay a dividend of 0.55 EUR.
The current dividend yield of Eckert & Ziegler Strahlen und Medizintechnik is 1.08 %.
Eckert & Ziegler Strahlen und Medizintechnik pays a quarterly dividend. This is distributed in the months of July, July, July, June.
Eckert & Ziegler Strahlen und Medizintechnik paid dividends every year for the past 23 years.
For the upcoming 12 months, dividends amounting to 0.55 EUR are expected. This corresponds to a dividend yield of 1.17 %.
Eckert & Ziegler Strahlen und Medizintechnik is assigned to the 'Health' sector.
To receive the latest dividend of Eckert & Ziegler Strahlen und Medizintechnik from 5/31/2024 amounting to 0.05 EUR, you needed to have the stock in your portfolio before the ex-date on 5/29/2024.
The last dividend was paid out on 5/31/2024.
In the year 2023, Eckert & Ziegler Strahlen und Medizintechnik distributed 0.5 EUR as dividends.
The dividends of Eckert & Ziegler Strahlen und Medizintechnik are distributed in EUR.
The Eckert & Ziegler Strahlen und Medizintechnik stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Our stock analysis for Eckert & Ziegler Strahlen und Medizintechnik Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eckert & Ziegler Strahlen und Medizintechnik Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.